Capricor Therapeutics
CAPR
#7978
Rank
HK$2.26 B
Marketcap
HK$49.49
Share price
-4.36%
Change (1 day)
-57.79%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -HK$0.64 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are HK$11.13 Million. In 2024 the company made an earning of -HK$0.32 Billion a decrease over its 2023 earnings that were of -HK$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.64 Billion103.14%
2024 -HK$0.32 Billion81.57%
2023 -HK$0.18 Billion-23.2%
2022 -HK$0.23 Billion44.93%
2021 -HK$0.16 Billion46.61%
2020 -HK$0.11 Billion78.71%
2019 -HK$59.46 Million-49.7%
2018 -HK$0.12 Billion-724.78%
2017 HK$18.91 M-112.93%
2016 -HK$0.15 Billion46.27%
2015 -HK$0.11 Billion106.82%
2014 -HK$48.37 Million-48.41%
2013 -HK$93.76 Million977.23%
2012 -HK$8.71 Million-77.11%
2011 -HK$38.03 Million-22.35%
2010 -HK$48.97 Million-20.17%
2009 -HK$61.35 Million-41.17%
2008 -HK$0.11 Billion41.05%
2007 -HK$73.93 Million1098.87%
2006 -HK$6.17 Million4101.55%
2005 -HK$0.15 Million-0.97%
2004 -HK$0.15 Million17.87%
2003 -HK$0.13 Million3.66%
2002 -HK$0.13 Million-30.11%
2001 -HK$0.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cytokinetics
CYTK
-HK$5.86 Billion 817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-HK$0.14 Billion-78.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.06 B-39,612.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$4.53 B-811.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$2 Billion 212.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-HK$73.84 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA